Syvento, a leading biotechnology company in RNA therapeutics, emerged at the recent RNA Leaders conference between March 13-14, 2024 in Basel, Switzerland.
Throughout the event, Syvento showcased its innovative contributions to the field by exhibiting at booth no. 21.
Visitors to the booth had the opportunity to engage with Syvento’s representatives, learn about the company’s cutting-edge research and development efforts, and explore its groundbreaking advancements in RNA delivery systems.
RNA Leaders, a prestigious conference dedicated to advancing RNA therapeutics, is taking place in Basel, Switzerland, bringing together experts from academia, industry, and research institutions. The event, held annually, serves as a platform for sharing cutting-edge discoveries, discussing challenges, and exploring opportunities in the field of RNA-based therapies.
This year’s conference featured a diverse range of topics, reflecting the rapid progress and growing interest in RNA therapeutics. Discussions are centered around various aspects of RNA biology, including RNA modification, delivery systems, and the latest advancements in RNA sequencing technologies. Additionally, sessions are focused on the development of RNA-based drugs for treating a wide array of diseases, from genetic disorders to cancer and infectious diseases.
One of the key highlights of the conference is the exploration of innovative strategies for enhancing the efficacy and safety of RNA therapeutics. Presenters will showcase novel delivery methods, such as lipid nanoparticles and exosome-based approaches, designed to overcome barriers to delivery and improve targeted delivery to specific tissues or cells.
